Impact Biomedical (IBO) Change in Inventory (2025)

Impact Biomedical's (IBO) quarterly Change in Inventory came in at -$3000.0 in Q4 2025, down 200.0% on a QoQ basis from -$1000.0 in Q3 2025.

Impact Biomedical (IBO) Change in Inventory (2025) Analysis & Trends

Impact Biomedical (IBO) has 1 years of Change in Inventory data on file, last reported at -$3000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Inventory (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	27.70 Mn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	28.20 Mn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	132.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	47.15 Mn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	-280,000.00
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	12.97 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	135.26 Mn
10	Impact Biomedical	49.45 Mn	49.44 Mn	2,000.00	-

Download Data